We believe that networking in R&D is key for
accelerated progress. We have developed major strengths in the areas of
Chemical Research, Bio-equivalent generics and Novel Drug Delivery System
(NDDS). We have taken initiatives to create infrastructure and capabilities in
the area of New Drug Discovery Research. We have state-of-art research and
development Facilities at our R&D Center.
Our NCE Pipeline
4-6* molecules in preclinical stage
(* 2molecules in collaboration with GSK)
1 Molecule in Phase II Clinicals :
Anti Malaria
Major Alliances/ Collaborations
Drug Discovery & Clinical Development
- GlaxoSmithKline
Cipro OD Technology Out Licensed - Bayer
Statin molecule out licensed to PPD, USA
Our Focus
New Drug Discovery Research(NDDR)
Metabolic Diseases
Respiratory/ Inflammatory
Anti-Infectives
Oncology
We seek partners for -
Co-development in the above therapeutic areas for collaboration
with companies / universities / research institutions to
undertake a discovery program starting from the conceptual
stage.
Novel Drug Delivery Systems (NDDS)
Our focus is on oral controlled release delivery systems
NDDS Technologies developed are on the following platforms
Multiparticulate
Modified matrix
Gastroretentive
Aerogel
Pharma Research
For Value Added Dosage Forms
Current
Soft gel
Dispersible tabs / chewable tabs
Taste masking
Gels
Effervescent
We seek opportunities for
Joint research projects for co - development of Novel Drug
Delivery System-based products.
